NeuroPace, Inc.
NPCE
$10.79
$0.363.45%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 22.14% | 27.00% | 30.75% | 42.07% | 43.72% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 22.14% | 27.00% | 30.75% | 42.07% | 43.72% |
Cost of Revenue | 20.36% | 18.98% | 17.37% | 28.32% | 32.79% |
Gross Profit | 22.78% | 30.11% | 36.16% | 47.64% | 48.10% |
SG&A Expenses | 4.74% | 3.02% | 3.65% | 7.39% | 6.19% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 9.70% | 7.96% | 5.96% | 8.53% | 7.28% |
Operating Income | 20.25% | 27.87% | 31.62% | 32.91% | 33.39% |
Income Before Tax | 17.64% | 25.89% | 29.54% | 31.50% | 30.00% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 17.64% | 25.89% | 29.54% | 31.50% | 30.00% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 17.64% | 25.89% | 29.54% | 31.50% | 30.00% |
EBIT | 20.25% | 27.87% | 31.62% | 32.91% | 33.39% |
EBITDA | 20.51% | 28.07% | 31.71% | 32.94% | 33.37% |
EPS Basic | 26.93% | 33.81% | 36.00% | 36.24% | 33.06% |
Normalized Basic EPS | 25.65% | 33.97% | 36.16% | 36.38% | 33.18% |
EPS Diluted | 26.58% | 33.51% | 35.73% | 35.99% | 33.06% |
Normalized Diluted EPS | 25.65% | 33.97% | 36.16% | 36.38% | 33.18% |
Average Basic Shares Outstanding | 12.68% | 11.79% | 9.81% | 7.47% | 5.10% |
Average Diluted Shares Outstanding | 12.68% | 11.79% | 9.81% | 7.47% | 5.10% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |